Navigation Links
Top10 research advances include studies on genetics and stem cell research, stents
Date:12/20/2007

Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents to clear coronary artery blockages are among the top research advances in heart disease and stroke for 2007, said Daniel W. Jones, M.D., president of the American Heart Association.

Other major milestones include a study that may change the way lives are saved using a new way to do cardiopulmonary resuscitation.

The American Heart Association in 1996 began compiling an annual list of the top 10 major advances in heart disease and stroke research and continues to highlight influential research annually.

Achievements in 2007 include:

  • 1. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

    Genome wide association studies identify genes (strands of DNA) which may cause specific diseases and represent a powerful approach in identifying genes involved in common human diseases. This large-scale genome-wide association (GWA) study found consistent and replicable genetic markers of several complex diseases of adulthood, including atherosclerotic heart disease. Study authors said their analysis of some 17,000 people for seven common familial diseases (bipolar disorder, coronary artery disease, Crohns disease, hypertension, rheumatoid arthritis, type 1 diabetes, and type 2 diabetes) confirms previously identified loci (DNA closely linked to genes that may identify a trait of a particular disease) and provides strong evidence for many novel disease susceptibility genes.
    Source: Nature, June 7, 2007; Nature 2007. 447:661-78; www.nature.com.
    Funding: Wellcome Trust was the principle funding source of this study.

  • 2. Genomewide association analysis of coronary artery disease

    This study included a joint analysis of two genomewide association studies of coronary artery disease. Researchers used the genetic patterns o
    '/>"/>


Contact: Cathy Lewis
cathy.lewis@heart.org
214-706-1324
American Heart Association
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...ANTON, Calif., July 25 /PRNewswire-FirstCall/ -- T...r in device-based mechanical,circulatory support t...ts,today announced that it will report its operat...onths of fiscal 2008 on Thursday, July 31., The c...financial,results and operating activities to all ...
(Date:7/25/2008)...rtain cleaning products reduces lung function, inc... FRIDAY, July 25 (HealthDay News) -- A clean, fres...h, depending on what type of cleaning and air fres...ests that exposure to cleaning products or air fre...mpound (VOC) called 1,4 dicholorobenzene (1,4 DCB)...
(Date:7/25/2008)...OK, Ill. July 25, 2008 The American Society for...elines on the role of endoscopy in the bariatric s...n the United States and the success in surgical in... of weight-loss surgeries performed in the U.S., f...nes discuss endoscopy in the preoperative patient ...
(Date:7/25/2008)...S, July 25 /PRNewswire/ -- BeaconEquity.com announ...ing news today., Investors can view all of the da...aconEquity.com/m , Today,s Trade Alerts include: ...Brook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaM...R ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis I...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3
...ing out of control, 'in'? A new report by the Ame...sy with reports of college girls and their wild (s... has revealed that breaking out of control and goi...ing fun in life. Three out of four women seem to g...
...art is under pressure as it is asked to improve it...llary Rodham Clinton who has had deep// ties with ...linton served on Wal-Mart's board of directors for...er time on the board of Wal-Mart was a memorable o...
...'s joy and relief at Norfolk as surgeons at the No...ven the green signal to make available the breast/... for her-2 gene. "We made the business case and ... groups, and the primary care trusts have backed t...
...esearch by the British Heart Foundation says that ... to fall a victim to heart disease than people// o...type 2 diabetes as compared to 3 percent of the ge...ate concern are the high rates of untreated diabet...
Other Medicine News:
(Date:7/24/2008)... NEW ORLEANS, July 24 /PRNewswire-USNewswire/ --...ped for mental illnesses, according to a new,repor...ed on the,devastating effects that mental illnesse...ationwide, mental illness affects nearly 60 millio...ceutical Research and Manufacturers,of America (Ph...
(Date:7/24/2008)... Revolutionary thermometer designed to take body...Fla., July 24 /-- Kidz-Med,... Inc. Pink Sheets: ASFX),United States distributo...eter, is pleased to announce the results of a clin...ic of the University of Milan, in,Milan, Italy, wh...
(Date:7/23/2008)... - Nexavar is First Approved Systemic Therapy to... Calif., July 23 /-,Bayer H..., Inc. (Nasdaq:,ONXX) today announced that The New...a Phase 3 trial demonstrating that Nexavar(R) (sor...th by 31 percent in patients with,unresectable hep...
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ -- ...of Justice:, Chairman Conyers, Ranking Member Smi...e opportunity to testify today., Since I appeared...ve,become even better acquainted with the talented...ment and with the work they do, and I have come to...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dr Charles A Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council 2703 1Dr Charles A Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council 2703 2Dr Charles A Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council 2703 3Tasker Products to Showcase Tasker Blue at International Poultry Expo 2698 1Tasker Products to Showcase Tasker Blue at International Poultry Expo 2698 2Tasker Products to Showcase Tasker Blue at International Poultry Expo 2698 3Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 1250 1Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 1250 2Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 1250 3Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 1250 4Researchers identify brains eureka circuitry 9955 1Researchers identify brains eureka circuitry 9955 2
...NGTON--(BUSINESS WIRE)--May 22, 2007 - Alequel(TM)...tion, may be an,effective treatment for moderate-t...going double-blind, placebo controlled Phase II,st...nduced good,clinical remissions and improved patie...researchers from Hebrew University-Hadassah,Medica...
... results report no new stent thrombosis after two ...s., and BARCELONA, Spain, May 22, 2007,/PRNewswire...,announced four-year follow-up data from its TAXUS... safety and efficacy benefits,associated with a mo...(TM) paclitaxel-eluting stent system -- which is n...
Other Medicine Technology:Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 2Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 3Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes,for Moderate-Release Paclitaxel-Eluting Stent at Four Years 2Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes,for Moderate-Release Paclitaxel-Eluting Stent at Four Years 3
Shafts angled 8 mm from tip to bend with smooth jaws. Flat, cross action handle with holes and dull finish.
Designed to accurately fold most flexible intraocular lens for ease of grasping with the folding instruments. The notched jaws align the implant and position it for a precise fold. Ideal for lens dia
Biconvex jaw design. 40 degree angled shafts. Tip to angle length: 7.5 mm. Locking handle. Manufacturing in titanium.
45 degree. Angled shafts. Tip to angle length: 11.5 mm. Stops in handle designed to prevent "over folding". Manufactured in titanium.
Medicine Products: